tag:blogger.com,1999:blog-14743001.post4784056977923413250..comments2024-01-02T02:45:17.328-06:00Comments on Notes from Dr. RW: Replacement therapy for alpha-1 antitrypsin deficiency “not recommended”Robert W Donnellhttp://www.blogger.com/profile/16944231400440786271noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-14743001.post-84534253848279303402010-08-06T08:37:02.557-05:002010-08-06T08:37:02.557-05:00Thanks for your thoughtful response to this review...Thanks for your thoughtful response to this review, Dr. Donnell.<br /><br />The Alpha-1 Foundation has challenged the Gøtzsche review as “so flawed in its methodology that it may threaten the reputation of the Cochrane Library.”<br /><br />Foundation President & CEO John Walsh said, “We hope that therapies for other rare conditions won’t become victims of the same poorly designed analysis.”<Bob Campbellhttp://www.alpha-1foundation.orgnoreply@blogger.comtag:blogger.com,1999:blog-14743001.post-85846194804628363842010-08-06T07:33:32.191-05:002010-08-06T07:33:32.191-05:00Thank you for a remarkably thoughtful response to ...Thank you for a remarkably thoughtful response to the Gøtzsche review, Dr. Donnell.<br /><br />The Alpha-1 Foundation has challenged the Gøtzsche review as “so flawed in its methodology that it may threaten the reputation of the Cochrane Library.”<br /><br />Foundation President & CEO John Walsh said, “We hope that therapies for other rare conditions won’t become victims of the same poorly Bob Campbellhttp://www.alpha-1foundation.orgnoreply@blogger.com